INTERNATIONAL PATENT: CARBIOGENE THERAPEUTICS CO., LTD., 浙江康佰裕生物科技有限公司 FILES APPLICATION FOR "DUAL-EPITOPE CAR AND DUAL-EPITOPE CAR-T CELL TARGETING CLL1 AND USE THEREOF"

GENEVA, Sept. 21 -- CARBIOGENE THERAPEUTICS CO., LTD. (Floor 20, Building No. 5, 688 Bin'an Road, Binjiang DistrictHangzhou, Zhejiang 310051), 浙江康佰裕生物科技有限公司 (中国浙江省杭州市滨江区滨安路688号5幢20层) filed a patent application (PCT/CN2025/091697) for "DUAL-EPITOPE CAR AND DUAL-EPITOPE CAR-T CELL TARGETING CLL1, AND USE THEREOF" on Apr 28, 2025. With publication no. WO/2025/190423, the details related to the patent application was published on Sep 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IP...